Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 15, 2022
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
[ Fri, Jul 15th 2022
] - WOPRAI
Brian Weinstein Downgraded (TXG) to Hold on, Jul 15th, 2022
Brian Weinstein of William Blair, Downgraded "10x Genomics, Inc." (TXG) to Hold on, Jul 15th, 2022.
Brian has made no other calls on TXG in the last 4 months.
There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $60 on, Thursday, July 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Brian
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $100 on, Friday, May 6th, 2022
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, May 5th, 2022
